Tibet Weixinkang Medicine Co., Ltd. (603676.SS) SHH
9.33
-0.22(-2.30%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Tibet Weixinkang Medicine Co., Ltd.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
689
First IPO Date
July 21, 2017
Key Executives
| Name | Title | Pay | Year Born |
| Xiaobing Zhou | Deputy General Manager | 0 | 1976 |
| Liqun Yao | Accounting Supervisor | 0 | N/A |
| Haibo Yu | Board Secretary | 0 | 1979 |
| Shigong Chen | Deputy GM & Director | 0 | 1973 |
| Yong Zhang | Chairman of the Board & GM | 0 | 1972 |
| Zizhong Weng | Deputy General Manager | 0 | 1964 |
| Yanxia Zheng | Financial Director | 0 | 1979 |
| Feng Liu | Vice Chairman & Deputy GM | 0 | 1973 |
Description
Tibet Weixinkang Medicine Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. The company's products include parenteral nutrition vitamins, electrolyte supplements, intravenous iron supplements, antibiotics, and medicine for digestive system and liver diseases. It also offers injection multivitamins, potassium magnesium aspartate for injection, iron sucrose injection, potassium aspartate injection, etc. The company was formerly known as Weixinkang Medicine Youxian Gongsi and changed its name to Tibet Weixinkang Medicine Co., Ltd. in 2015. Tibet Weixinkang Medicine Co., Ltd. was founded in 2006 and is based in Lhasa, China.
